Physician profile
Rahul Vasudev
NPI 1689081325
$23,751.27
in general payments reported to CMS, 2019-2025
15 companies · $3,009 in 2025
The $3,009 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.32 · 2020: $257 · 2021: $9,718 · 2022: $4,573 · 2023: $2,208 · 2024: $3,934 · 2025: $3,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,812 · Travel and Lodging: $2,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,811.71 |
| Travel and Lodging | $2,338.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,051.09 | 2020-2025 | Triclip, Navitor, Mitraclip |
| Medtronic, INC. | $6,731.67 | 2021-2025 | Corevalve Evolut R, N/A |
| Edwards Lifesciences Corporation | $2,021.52 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $958.58 | 2020-2025 | Watchman Flx, Watchman Access System |
| W. L. Gore & Associates, INC. | $840.85 | 2022-2024 | Gore Cardioform Septal Occluder |
| E.R. Squibb & Sons, L.L.C. | $344.96 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $268.01 | 2020-2023 | Farxiga |
| Inari Medical, INC. | $105.35 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ancora Heart, INC. | $102.58 | 2022 | |
| Shockwave Medical, INC | $98.45 | 2023-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abiomed | $75.53 | 2022-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $72.86 | 2024-2025 | |
| Pfizer INC. | $33.73 | 2020-2024 | |
| Stryker Corporation | $27.72 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Atricure, INC. | $18.37 | 2025 | Atriclip Laa Exclusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Vasudev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.